Invenomic Capital Management Boosts Stake in DENTSPLY SIRONA

Institutional investor increases position in medical instruments supplier by nearly 50%

Mar. 16, 2026 at 12:20pm

Invenomic Capital Management LP has increased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 48.7% during the 3rd quarter, according to a recent SEC filing. The institutional investor now owns 4,351,199 shares of the medical instruments supplier's stock, making it the company's second-largest position and accounting for 2.18% of Invenomic's portfolio.

Why it matters

This move by Invenomic Capital Management signals increased institutional confidence in DENTSPLY SIRONA, a leading global manufacturer of professional dental products and technologies. The stock has seen volatility in recent quarters, but the sizable increase in Invenomic's stake suggests the firm believes the company's long-term prospects remain strong.

The details

According to the SEC filing, Invenomic Capital Management purchased an additional 1,425,637 shares of DENTSPLY SIRONA during the 3rd quarter, bringing its total position to 4,351,199 shares. This represents a 48.7% increase in the firm's stake in the medical instruments supplier.

  • Invenomic Capital Management increased its DENTSPLY SIRONA holdings during the 3rd quarter of 2026.

The players

Invenomic Capital Management LP

An institutional investor that has significantly increased its stake in DENTSPLY SIRONA, making it the company's second-largest shareholder.

DENTSPLY SIRONA Inc.

A leading global manufacturer of professional dental products and technologies, headquartered in Charlotte, North Carolina.

Got photos? Submit your photos here. ›

The takeaway

This move by Invenomic Capital Management suggests growing institutional confidence in DENTSPLY SIRONA's long-term prospects, despite recent stock price volatility. The significant increase in the firm's stake highlights the medical instruments supplier's position as a key player in the dental technology industry.